Skip to content

Radiofrequency Neurotomy In Relieving Chronic Knee Pain

Fluoroscopic Guided Radiofrequency of Genicular Nerves for Pain Alleviation in Chronic Knee Osteoarthritis : A Single-blind Randomized Controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03224637
Enrollment
60
Registered
2017-07-21
Start date
2014-07-31
Completion date
2016-02-29
Last updated
2017-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteo Arthritis Knee, Pain, Chronic

Brief summary

Osteoarthritis (OA) affects aged above 45 years. RF has been used for several painful conditions. There have been a few attempts to use RF current for the treatment of painful conditions of joints of the extremities. It was also used for the treatment of painful conditions of the hip joint.

Detailed description

Osteoarthritis (OA) is commonest chronic arthritis affecting patients usually aged above 45 years. OA decreased health-related quality of life and increased economic costs. Radiofrequency (RF), was used for the treatment of chronic pain unresponsive to conservative therapies. RF has been used for several painful conditions. There have been a few attempts to use RF current for the treatment of painful conditions of joints of the extremities. It was also used for the treatment of painful conditions of the hip joint.

Interventions

PROCEDUREradiofrequency

radiofrequency done in the three genicular nerves upper medial and upper lateral and lower medial

DRUGParacetamol (conventional)
DRUGKetorolac Tromethamine (conventional)

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* chronic arthritis according to the American College of Rheumatology criteria * diagnosed radiologically patients in stage 3 and 4, according to the Kellgren-Lawrence classification

Exclusion criteria

* other causes of pain such as radiculopathy, neurological disorders, or intermittent claudication. * patients receive intraarticular steroid or hyaluronic acids during previous three months. * patients did previous knee surgery. * Patients with general contraindication to the application of invasive intervention such as hemorrhage, coagulation disorder, systemic infection or local infection. * patients with other connective tissue disease affecting the knee. And 6-psychiatric disorders.

Design outcomes

Primary

MeasureTime frameDescription
pain assessment by VAS scale6 monthsassessing pain by VAS scale

Secondary

MeasureTime frameDescription
patient satisfaction by Likert scale6 monthsLikert scale to assess patients satisfaction
patient disability by Western Ontario McMaster Universities OA index6 monthsWestern Ontario McMaster Universities OA index to assess disability

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026